Dies ist eine Übersichtsseite mit Metadaten zu dieser wissenschaftlichen Arbeit. Der vollständige Artikel ist beim Verlag verfügbar.
The barriers to uptake of artificial intelligence in hepatology and how to overcome them
13
Zitationen
16
Autoren
2025
Jahr
Abstract
Artificial intelligence (AI) methods in hepatology have proliferated since the mid-2010s, with numerous publications and some regulatory approvals. Yet, adoption of AI methods in real-world clinical practice and clinical research remains limited. Despite clear benefits of using AI to analyse complex data types in hepatology, such as histopathology, radiology images, multi-omics and more recently, natural language patient data, there are still substantial barriers and challenges to its integration into routine clinical workflows. In this position paper, we assess limitations and propose a set of clear recommendations aimed at both the development of AI systems and the broader hepatology environment to facilitate the transition of AI-based diagnostic, prognostic, and predictive tools into clinical care. In particular, we argue that the use of AI in clinical trials, seamless integration into hospital information systems and building AI literacy among clinicians will ultimately drive clinical adoption. We validate this perspective through a Delphi consensus involving 34 international experts from hepatology, AI, and data science, ensuring a comprehensive and consensus-driven evaluation of our recommendations.
Ähnliche Arbeiten
Explainable Artificial Intelligence (XAI): Concepts, taxonomies, opportunities and challenges toward responsible AI
2019 · 8.316 Zit.
Stop explaining black box machine learning models for high stakes decisions and use interpretable models instead
2019 · 8.177 Zit.
High-performance medicine: the convergence of human and artificial intelligence
2018 · 7.575 Zit.
Proceedings of the 19th International Joint Conference on Artificial Intelligence
2005 · 5.776 Zit.
Peeking Inside the Black-Box: A Survey on Explainable Artificial Intelligence (XAI)
2018 · 5.468 Zit.
Autoren
Institutionen
- RWTH Aachen University(DE)
- Vall d'Hebron Institute of Oncology(ES)
- Hospital Clínic de Barcelona(ES)
- Consorci Institut D'Investigacions Biomediques August Pi I Sunyer(ES)
- Universitat de Barcelona(ES)
- Düsseldorf University Hospital(DE)
- Heinrich Heine University Düsseldorf(DE)
- King's College London(GB)
- Inserm(FR)
- Université Paris-Est Créteil(FR)
- Institut Mondor de Recherche Biomédicale(FR)
- Fresenius (Germany)(DE)
- Nuffield Orthopaedic Centre(GB)
- Vanderbilt University Medical Center(US)
- Centro de Investigación Biomédica en Red de Enfermedades Hepáticas y Digestivas(ES)
- Université Libre de Bruxelles(BE)
- Heidelberg University(DE)
- University Hospital Heidelberg(DE)
- National Center for Tumor Diseases(DE)
- University Hospital Carl Gustav Carus(DE)